8-K: inTEST Corporation Acquires Alfamation S.p.A. and Announces Restatement of Financial Results

inTEST Corporation has acquired Alfamation S.p.A., expanding its electronic test capabilities, while also announcing a restatement of its third quarter 2023 financial results due to revenue recognition errors.

Summary

• inTEST Corporation has acquired Alfamation S.p.A. for approximately 20 million, consisting of 18 million in cash, 187,432 shares of inTEST common stock, and an additional 542 thousand in cash for assets delivered at closing.
• Alfamation, based in Italy, is a provider of test and measurement solutions for the automotive, life sciences, and consumer electronics markets, with annual revenue of approximately $25 million.
• The acquisition is expected to be accretive to inTEST's non-GAAP adjusted earnings per diluted share in 2025, but dilutive to earnings per diluted share in 2024.
• inTEST also announced a restatement of its third quarter 2023 financial results, reducing revenue by approximately $1.7 million and net income by approximately $700,000.
• The restatement is due to errors in revenue recognition related to the sale of discontinued material/components purchased on behalf of customers.
• The company expects to file restated financial statements for the third quarter 2023 as soon as reasonably practical.
• Full year 2024 revenue is expected to be in the range of $145 million to $155 million.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. The acquisition is a positive development for growth, but the restatement of financials and expected dilution in 2024 temper the overall outlook. The material weakness in internal controls is also a concern.

Positives

• The acquisition of Alfamation expands inTEST's presence in the automotive/EV and life science markets.
• Alfamation brings strong engineering talent and a management team that aligns with inTEST's mission.
• Alfamation's product portfolio includes innovative test solutions such as Hyperion, WALOTTM, and PixelshooterTM.
• The acquisition is expected to be accretive to non-GAAP adjusted earnings per diluted share in 2025.
• Alfamation has demonstrated healthy, double-digit, annual revenue growth over the last few years.

Negatives

• The acquisition is expected to be dilutive to earnings per diluted share in 2024.
• inTEST is restating its third quarter 2023 financial results due to revenue recognition errors.
• The restatement will reduce earnings per diluted share for the third quarter 2023 from $0.24 to $0.19.
• The company expects to report a material weakness in its internal control over financial reporting.

Risks

• The integration of Alfamation's operations may present challenges.
• The restatement of financial results may negatively impact investor confidence.
• The company may face challenges in managing supply chain issues and converting backlog to sales.
• The company may be affected by changes in market cycles and general economic conditions.
• The company may face challenges in accessing capital and borrowing funds for future acquisitions or working capital.

Future Outlook

The company expects the acquisition to be accretive to non-GAAP adjusted earnings per diluted share in 2025. Full year 2024 revenue is expected to be in the range of $145 million to $155 million. The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted earnings per diluted share.

Management Comments

• Nick Grant, President and CEO, commented, 'We identified the opportunity with Alfamation through our disciplined pursuit for acquisitions that will enhance our innovative test and process technology solutions and further strengthen our position in key target markets.'
• Nick Grant also stated, 'We believe this acquisition is an excellent fit for our Electronic Test division and advances all dimensions of our 5-Point Strategy.'

Industry Context

This acquisition aligns with the trend of consolidation in the test and measurement industry, as companies seek to expand their product portfolios and geographic reach. The focus on automotive/EV, life sciences, and consumer electronics markets reflects the growing demand for advanced testing solutions in these sectors.

Comparison to Industry Standards

• The acquisition of Alfamation is similar to other strategic acquisitions in the test and measurement industry, such as Keysight Technologies' acquisition of Ixia, which aimed to expand their capabilities and market reach.
• Alfamation's revenue of $25 million is comparable to other mid-sized players in the industry, and the acquisition is expected to significantly increase inTEST's scale.
• The restatement of financial results is not uncommon in the industry, as companies sometimes face challenges in revenue recognition, as seen with other companies such as Xilinx in the past.
• The expected dilutive impact on earnings per share in 2024 is typical for acquisitions, as companies often incur integration costs and amortization of intangible assets.

Stakeholder Impact

• Shareholders may experience short-term dilution in earnings per share due to the acquisition.
• Employees of both inTEST and Alfamation may experience changes due to the integration process.
• Customers of both companies may benefit from a broader range of products and services.
• Suppliers of both companies may see changes in their business relationships.

Next Steps

• The company will file restated financial statements for the third quarter 2023.
• The company will file its 2023 10-K as soon as practical.
• The company will host a conference call following the filing and release of fourth quarter 2023 financial results.
• The company will integrate Alfamation into its Electronic Test division.

Key Dates

Keywords

acquisition, Alfamation, inTEST Corporation, electronic test, revenue restatement, financial results, test solutions, automotive, life sciences, consumer electronics, backlog, earnings per share, non-GAAP, material weakness, internal control